Beijing Beilu Pharmaceutical Co., Ltd. (SZSE: 300016)
Health Care · Pharmaceuticals · CN
CN¥10.44
+19.59% today · +1.4% 1Y
Beijing Beilu Pharmaceutical Co., Ltd. (SZSE: 300016) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $903.37M and employs 1,188 people.
Over the last twelve months the share price has gained 1.4%, trading between 7.08 and 11.38.
Tweenvest scores Beijing Beilu Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 40/100, growth 47/100. Its strongest factor is quality.
300016 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $903.37M
- Revenue (TTM)
- $180.21M
- P/E
- 45.31
- EPS
- 0.23
- Dividend yield
- —
- Beta (5Y)
- 0.26
- 52-week high
- CN¥11.38
- 52-week low
- CN¥7.08
- Avg volume (3M)
- —
- Shares outstanding
- 581.69M
- Employees
- 1,188
- Next earnings
- —
About Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co., Ltd., established in 1992 and headquartered in Beijing, China, operates within the pharmaceutical industry. The company is primarily involved in the research, development, production, and commercialization of diverse medicinal products. Its offerings notably include specialized drugs like contrast agents, treatments for central nervous system conditions, and oral medications designed for diabetes. Additionally, Beilu Pharmaceutical also ventures into the manufacturing of precision medicine.
- ISIN
- CNE000001QK9
- Founded
- 1992
- Listed since
- Oct 30, 2009
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,244.81 | -0.84% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.91 | +0.62% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $151.14 | -0.92% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.10 | -1.46% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.74 | -1.36% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.06 | -0.05% |
Figures last refreshed Aug 18, 2026.